TABLE 1.
Clinical characteristics of study participants.
| Characteristics | ALS group (n = 15) | Control group (n = 16) | P-value | |
| Age (years)(a,b,c) | 71.0, 64.4 ± 2.649, 47–80 | 60, 66 ± 2.954, (49–85) | 0.726# | |
| Sex | Male | 8 (53.33%) | 9 (56.25%) | >0.999¶ |
| Female | 7 (46.67%) | 7 (43.75%) | ||
| Onset | Bulbar | 1 (6.67%) | – | |
| Limb | 14 (93.33%) | – | ||
| PMI (b)* | 13.73 ± 2.11 h (n = 11) | 16.33 ± 2.08 h (n = 9) | 0.396# | |
| ALS Classification | Familial | 0 | – | |
| Sporadic | 16 (100%) | – | ||
| Ethnicity | Caucasian | 15 (100%) | 15 (93.75) | |
| Black/AA | – | 1 (6.25%) | ||
(a) median; (b) mean ± standard error; (c) range; *For autopsy tissue, no data available from one participant. AA, African American; PMI, Postmortem Interval; #student t-test; ¶Fisher’s exact test.